Literature DB >> 28463035

Inhibition of NF-κB/TNF-α pathway may be involved in the protective effect of resveratrol against cyclophosphamide-induced multi-organ toxicity.

Azza A El-Sheikh1,2, Mohamed A Morsy1,3, Ahmed M Okasha4.   

Abstract

CONTEXT: Cyclophosphamide (CyP), an efficient anticancer drug, may damage normal human cells. Resveratrol (RES), a natural polyphenol, has a diverse pharmacological properties.
OBJECTIVE: To test possible protective effect of RES on multi-organ damage caused by CyP.
MATERIALS AND METHODS: RES (10 mg/kg/day) was administered orally for 8 days. In independent rat groups, CyP toxicity was induced via a single dose of 150 mg/kg i.p. 3 days before the end of experiment, with or without RES treatment.
RESULTS: Compared to control, CyP caused significant increase in organ-to-body weight ratios of heart, kidney and liver, with deterioration in their functional parameters; namely serum creatine kinase, blood urea nitrogen, creatinine, alanine aminotransferase and aspartate aminotransferase. CyP also caused distortion in these organs' histology, with significant tissue oxidative stress, manifested by decrease in reduced glutathione and catalase, as well as increase in malondialdehyde and nitric oxide levels. Furthermore, CyP caused multi-organ inflammatory effects as shown by increased tumor necrosis factor-α levels, as well as up-regulation of nuclear factor-κB expressions. Using RES concurrently with CyP restored heart, kidney and liver functional parameters, as well as their normal histology. RES also reversed oxidative stress, as well as inflammatory signs caused by CyP alone.
CONCLUSIONS: RES may be beneficial adjuvant that confers multi-organ protection against CyP toxicity via antioxidant and anti-inflammatory mechanisms.

Entities:  

Keywords:  Cyclophosphamide; nuclear factor-κB; reduced glutathione; resveratrol; tumor necrosis factor-α

Mesh:

Substances:

Year:  2017        PMID: 28463035     DOI: 10.1080/08923973.2017.1318913

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  9 in total

Review 1.  Resveratrol as a modulatory of apoptosis and autophagy in cancer therapy.

Authors:  R Yang; H Dong; S Jia; Z Yang
Journal:  Clin Transl Oncol       Date:  2022-01-17       Impact factor: 3.405

Review 2.  The Role of Antioxidants in Ameliorating Cyclophosphamide-Induced Cardiotoxicity.

Authors:  Muluken Altaye Ayza; Kaleab Alemayehu Zewdie; Bekalu Amare Tesfaye; Dawit Zewdu Wondafrash; Abera Hadgu Berhe
Journal:  Oxid Med Cell Longev       Date:  2020-05-10       Impact factor: 6.543

3.  The Effect of Polyphenolic Composition BP-C3 on the Efficacy and Hematological Toxicity of Cyclophosphamide in the Chemotherapy of Mice Bearing Soft Tissue Sarcomas Induced by Benzo[a]pyrene.

Authors:  Andrey V Panchenko; Elena I Fedoros; Sergey E Pigarev; Mikhail A Maydin; Ekaterina A Gubareva; Galina S Kireeva; Margarita L Tyndyk; Anastasia I Kuznetsova; Tatyana L Nekhaeva; Anna B Danilova; Irina A Baldueva; Vladimir N Anisimov
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

4.  Myricetin Abrogates Cisplatin-Induced Oxidative Stress, Inflammatory Response, and Goblet Cell Disintegration in Colon of Wistar Rats.

Authors:  Muneeb U Rehman; Irfan A Rather
Journal:  Plants (Basel)       Date:  2019-12-24

5.  CYP1B1 as a therapeutic target in cardio-oncology.

Authors:  Alexa N Carrera; Marianne K O Grant; Beshay N Zordoky
Journal:  Clin Sci (Lond)       Date:  2020-11-13       Impact factor: 6.124

6.  Genoprotective activity of the Pleurotus eryngii mushrooms following their in vitro and in vivo fermentation by fecal microbiota.

Authors:  Athina Boulaka; Panagiota Mantellou; Gabriela-Monica Stanc; Efthymia Souka; Christoς Valavanis; Georgia Saxami; Evdokia Mitsou; Georgios Koutrotsios; Georgios I Zervakis; Adamantini Kyriacou; Vasiliki Pletsa; Panagiotis Georgiadis
Journal:  Front Nutr       Date:  2022-08-23

7.  Morphine Deteriorates Cisplatin-Induced Cardiotoxicity in Rats and Induces Dose-Dependent Cisplatin Chemoresistance in MCF-7 Human Breast Cancer Cells.

Authors:  Azza A K El-Sheikh; Zenat Khired
Journal:  Cardiovasc Toxicol       Date:  2021-04-01       Impact factor: 3.231

8.  A novel protective role of sacubitril/valsartan in cyclophosphamide induced lung injury in rats: impact of miRNA-150-3p on NF-κB/MAPK signaling trajectories.

Authors:  Ghada A Abdel-Latif; Azza H Abd Elwahab; Rehab A Hasan; Noura F ElMongy; Maggie M Ramzy; Manal L Louka; Mona F Schaalan
Journal:  Sci Rep       Date:  2020-08-03       Impact factor: 4.379

9.  NF-κB/p65 Competes With Peroxisome Proliferator-Activated Receptor Gamma for Transient Receptor Potential Channel 6 in Hypoxia-Induced Human Pulmonary Arterial Smooth Muscle Cells.

Authors:  Yan Wang; Naijian Li; Yingfeng Wang; Guobing Zheng; Jing An; Chang Liu; Yajie Wang; Qicai Liu
Journal:  Front Cell Dev Biol       Date:  2021-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.